Lv54
1348 积分 2025-05-09 加入
Cost-Effectiveness of Escitalopram versus Citalopram in the Treatment of Severe Depression
14天前
已完结
Spotlight on the Pharmacoeconomics of Escitalopram in Depression1
14天前
已完结
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland☆
14天前
已完结
Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany
14天前
已完结
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
14天前
已完结
Cost-effectiveness of atezolizumab plus chemotherapy for advanced non-small-cell lung cancer
28天前
已完结
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
1个月前
已完结
Efficacy of immune checkpoint inhibitors in the first line therapy of non-squamous non-small cell lung cancer: A systematic review and network meta-analysis
1个月前
已关闭
Efficacy and safety of first-line treatments with immune checkpoint inhibitors plus chemotherapy for non-squamous non-small cell lung cancer: a meta-analysis and indirect comparison
1个月前
已关闭
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial
3个月前
已关闭
皖公网安备34019202002308
